Professional Documents
Culture Documents
• Modes of transmission:
Vector-borne parasite infection via
female Anopheles mosquito
Chikungunya
• Causative organisms:
Chikungunya Virus of Togaviridae Family
• Modes of transmission:
Vector-borne viral infection via mosquito bite:
-Aedes albopictus
Japanese Encephalitis
• Causative organisms:
Japenese Encephalitis Virus
• Modes of transmission:
Vector-borne viral infection via mosquito bite:
-Culex tritaeniorhynchus
Leptospirosis
• Causative organisms:
Leptospira Interrogans
• Modes of transmission:
i. Direct contact with urine or tissue of infected animal
-Through skin abrasions, intact mucus membrane
ii. Indirect contact
-Broken skin infected soil, water or vegetation
-Ingestion of contaminated food & water
iii. Droplet infection
-Inhalation of droplets of infected urine.
Mode of Transmission of Leptospirosis
Disease, Causative Organisms and Mode of Transmission
8/1/2018 COMMED 42
CLINICAL SIGNS
8/1/2018 COMMED 43
CLINICAL SIGNS
8/1/2018 COMMED 44
HOW DO WE DIAGNOSE?
I. DENGUE FEVER
Probable diagnosis
Acute febrile illness with two or more of the following;
o headache,
o retro-orbital pain,
o myalgia,
o arthralgia/bone pain,
o rash,
o haemorrhagic manifestations,
o leucopenia (wbc s 5000 cells/mm3),
o thrombocytopenia (platelet count <150,000 cells/mm3),
o rising haematocrit (5-10%);
o and at least one of following :
o supportive serology on single serum sample: titre :2: 1280 with
haemagglutination inhibition test, comparable IgG titre with enzyme-linked
immunosorbent assay, or testing positive in lgM antibody test, and
occurrence at the same locationCOMMED
8/1/2018 and time as · confirmed cases of dengue
45
Confirmed diagnosis
Probable case with at least one of the following :
o isolation of dengue virus from serum, CSF or autopsy samples.
o fourfold or greater increase in serum lgG (by
haemagglutination inhibition test) or increase in lgM antibody
specific to dengue virus.
o detection of dengue virus or antigen in tissue, serum or
cerebrospinal fluid by immunohistochemistry,
immunofluorescence or enzyme-linked immunosorbent assay.
o detection of dengue virus genomic sequences by reverse
transcription-polymerase chain reaction.
8/1/2018 COMMED 46
II. DENGUE HAEMORRHAGIC FEVER
All of following :
o acute onset of fever of two to seven days duration.
o haemorrhagic manifestations, shown by any of the
following;
o positive tourniquet test
o petechiae
o ecchymoses or purpura
o bleeding from mucosa,
o gastrointestinal tract
o injection sites
o platelet count S: 100,000 cells/mm3 ·vascular permeability
shown by any of the following :
o Rising haematocrit/haemoconcentration ~ 20% from baseline
or evidence of plasma leakage such as pleural effusion, ascites
or hypoproteinaemia/ albuminaemia.
8/1/2018 COMMED 47
III. DENGUE SHOCK SYNDROME
8/1/2018 COMMED 48
LAB DIAGNOSIS
I. Virus isolation :
o Isolation of dengue virus from clinical specimens is possible
provided the specimen is taken during the first six days of illness
and processed without delay.
o Specimen that are suitable for virus isolation are acute phase
serum, plasma or washed b\lffY coat from the patient,autopsy
tissue from fatal case (especially liver, spleen, lymph nodes and
thymus), and mosquitoes collected from the affected areas.
II. Viral nucleic acid detection :
o Dengue viral genome, which consists of RNA, can be detected by
reverse transcriptase polymerase chain reaction (RT -PCR) assay
and real time RT-PCR. In recent years, a number of RT
o PCR assays have been reported for detecting dengue virus.
o They offer better specificity and sensitivity compared to virus
isolation with a much more rapid turnaround time.
8/1/2018 COMMED 49
III. Immunological response and serological tests
Following tests are available for diagnosis of dengue infection:
f. IgM/IgG ratio
8/1/2018 COMMED 50
IV. Viral antigen detection : ELISA and dot blot assays
o directed against the envelop/membrane (EM) antigens and
8/1/2018 COMMED 51
V. Rapid diagnostic test (RDT)
o A number of commercial rapid format serological test-kits for
anti-dengue IgM and IgG antibodies have become available in
the past few years
o some of these producing results within 15 minutes.
o Unfortunately, the accuracy of most of these tests is uncertain
since they have not yet been properly validated.
8/1/2018 COMMED 52
8/1/2018 COMMED 53
MALARIA
8/1/2018 COMMED 54
Clinical Signs
Clinical symptoms include the following:
o Headache (noted in virtually all patients with malaria)
o Cough
o Fatigue
o Malaise
o Shaking chills
o Arthralgia
o Myalgia
o Paroxysm of fever, shaking chills, and sweats (every 48 or 72
hours, depending on species)
Less common symptoms include the following:
o Anorexia and lethargy
o Nausea and vomiting
o Diarrhea
o Jaundice
8/1/2018 COMMED 55
Most patients with malaria have no specific physical findings,
but splenomegaly may be present. Severe malaria manifests as
the following:
o Cerebral malaria (sometimes with coma)
o Severe anemia
o Respiratory abnormalities: Include metabolic acidosis,
associated respiratory distress, and pulmonary edema; signs
of malarial hyperpneic syndrome include alar flaring, chest
retraction, use of accessory muscles for respiration, and
abnormally deep breathing
o Renal failure (typically reversible)
8/1/2018 COMMED 56
Clinical Signs
The typical attack comprises three distinct stages, i.e. the cold stage, the hot stage
and the sweating stage. These are followed by an afebrile period in which the
patient feels greately relieved.
COLD STAGE :
• Onset: lassitude, headache, nausea, chilly sensation followed in an hour or so by
rigors.
• Temperature rises rapidly to 39-41°C.
• Severe headache and vomiting. In early part of this stage, skin feels cold; later it
becomes hot.
• Parasites are usually demonstrable in the blood. Pulse is rapid and may be weak.
This stage lasts for 1/4-1 hour.
HOT STAGE :
• Patient feels burning hot and casts off his clothes. Skin is hot and dry to touch.
• Headache is intense but nausea commonly diminishes.
• The pulse is full and respiration rapid. This stage lasts for 2 to 6 hours.
8/1/2018 COMMED 57
SWEATING STAGE :
• Fever comes down with profuse sweating. The temperature
drops rapidly to normal & skin is cool and moist. The pulse rate
becomes slower, patient feels relieved and often falls asleep.
• This stage lasts for 2-4 hours. The febrile paroxysms occur
intermittent periodicity repeating every third or fourth day
depends the species of the parasite involved.
• The classical 3 stages (cold, hot and sweating) may not always
be observed due to maturation of generations of parasite at
different times. Periods of latency may last several weeks or
months (8, 19).
• The disease has a tendency to relapse and is characterized by
splenomegaly and secondary anemia. Febrile herpes is
common in all malarial patients.
Lab Diagnosis
1. Microscopy
• Two types of blood films.
• The "thin film" and the "thick film". It is recommended that both types of film be
prepared on a single microscope glass slide. The thick film is more reliable in
searching for parasite, as large volume of blood is examined under each
microscope field. When scanty, parasite may be found about 20 times more rapidly
in thick slide than in thin slide. The thin slide is more valuable for identifying the
species of the parasite present. In it they are seen more clearly. The advantage of
microscopy are : The sensitivity is high. It is possible to detect malarial parasite
at low densities. It also helps to quantify the parasite load; It is possible to
distinguish the various species of malaria parasite and their different stages.
8/1/2018 COMMED 59
Specific tests for malaria infection should be carried out, as follows:
o Microhematocrit centrifugation (sensitive but incapable of speciation)
o Fluorescent dyes/ultraviolet indicator tests (may not yield speciation
information)
o Thin (qualitative) or thick (quantitative) blood smears (standard): Note that
1 negative smear does not exclude malaria as a diagnosis; several more
smears should be examined over a 36-hour period
o Include rapid diagnostic tests, polymerase chain reaction assay, nucleic acid
sequence-based amplification, and quantitative buffy coat
8/1/2018 COMMED 60
8/1/2018 COMMED 61
8/1/2018 COMMED 62
8/1/2018 COMMED 63
CHIKUGUNYA
8/1/2018 COMMED 64
Clinical Signs
Clinical examination reveals
o high-grade fevers (up to 105°F), pharyngitis, conjunctival
suffusion
o Conjunctivitis
o Photophobia
o Other frequent manifestations include severe arthralgias,
myalgias, and rash.
8/1/2018 COMMED 65
Lab Diagnosis
Several methods can be used for diagnosis.
Confirmation Test
o Serological tests – ELISA = may confirm the presence of
IgM and IgG anti-chikungunya antibodies. IgM antibody
levels are highest 3 to 5 weeks after the onset of illness and
persist for about 2 months.
o Samples collected during the first week after the onset of
symptoms should be tested by both serological and
virological methods (RT-PCR).
o The virus may be isolated from the blood during the first
few days of infection. Various reverse transcriptase–
polymerase chain reaction (RT–PCR) methods are available
but are of variable sensitivity.
8/1/2018 COMMED 66
JAPANESE ENCEPHALITIS
8/1/2018 COMMED 67
Lab Diagnosis
o The virus can be isolated from the blood of febrile patients
by the intracerebral inoculation in suckling mice or on
VERO cells.
o In serologic diagnosis, which is the approach most
commonly used, sero-conversion is demonstrated by
comparing acute and convalescent - phase sera in the
haemagglutination inhibition, serum neutralization, or
complement fixation test.
o The enzyme-linked immunosorbent assay (ELISA) is used
to detect lgM. A reverse-transcription polymerase chain
reaction (RT-PCR) I nested PCR technique has also been
shown to be useful in rapidly diagnosing the disease.
8/1/2018 COMMED 68
LEPTOSPIROSIS
8/1/2018 COMMED 69
Clinical Signs
It is characterized by sudden onset of the following:
o Fever (38-40°C)
o Rigors
o Headache, retro-orbital pain, photophobia
o Conjunctival suffusion
o Dry cough
o Nausea and vomiting, diarrhea
o Muscle pain localized to the calf and lumbar areas
More severe disease manifests as icteric leptospirosis, also known as
Weil disease, with the following features:
o Icterus or frank jaundice
o Renal failure with oliguria
o Hemorrhagic features
o Systemic inflammatory syndrome or shock
8/1/2018 COMMED 70
Lab Diagnosis
I. Leptospira immunoglobulin M (IgM) ELISA or
IgM/immunoglobulin G (IgG) enzyme-linked immunoabsorbent
assay (ELISA), including rapid diagnostic kits usable in the field
Real-time DNA polymerase chain reaction (PCR) of blood, urine,
and cerebrospinal fluid (CSF)
Confirmation Test
o Microscopic agglutination testing (MAT; criterion standard for
serologic identification of leptospires, available at reference
laboratories)
o Single titer ≥1:200 or 4-fold rise in serum drawn between the
first and fourth week of illness is considered diagnostic
o DNA PCR of blood, urine, CSF, tissue
o Culture of leptospires from body fluids or tissue (criterion
standard, but requires specific media and several weeks’
incubation, thus usually limited
8/1/2018 to reference laboratory)
COMMED 71
Lab Diagnosis
o Early in the disease, the organism may be identified by dark-
field examination of the patient's blood or by culture on a
semisolid medium. Culture takes 1-6 weeks to become positive.
The organism may also be grown from the urine from 10th day
to 6 weeks.
o Diagnosis is usually made by means of serological tests, of
which several are available. Agglutination tests (microscopic
using live organism, and macroscopic using killed antigen)
become positive after 7-10 days of illness and peak at 3-4
weeks and may persist at high level for many years. Indirect
haemagglutination, immunoflourescent antibody and ELISA
tests are also available. The IgM ELISA is particularly useful in
making an early diagnosis, as it is positive as early as 2 days
into illness. Now Leptodipstick test is also available.
8/1/2018 COMMED 72
8/1/2018 COMMED 73
3. PREVENTION , PROMOTION AND CONTROL
Prevention and control of Dengue
• Secondary prevention:
– Construct system for monitoring number of infections.
– Mechanism for responding to epidemic promptly.
– To upgrade the effectiveness of laboratory diagnosis.
Prevention and control of Dengue
• Tertiary prevention:
– Prevent advanced cases that cause death:
• Target: reduce death rate of dengue hemorrhagic fever to <
5%.
– Train medical treatment personnel of dengue hemorrhagic fever.
– Amend standards for designated hospitals in treating fatal dengue
hemorrhagic fever in an emergency.
– Select hospitals for treating dengue hemorrhagic fever in an
emergency.
– Create mechanism for allocating hospital beds in an emergency.
Prevention and control of Malaria
Primary prevention :
1.Awareness and Education of the risk of malaria:
1.Recognizing the disease in the early stages can stop
the disease from becoming a killer.
Sources :
https://www.moh.gov.sg/content/dam/moh_web/PressRoom/Current_Issues/2005/DengueAdvisory.pdf
i. White cell count (WCC) and Platelet count:
• In the early febrile phase WCC and platelet count are usually normal but will
decrease rapidly as the disease progresses. The decrease in WCC is
accompanied by platelet reduction. There is no correlation between
disease severity and platelet count and it is not predictive of bleeding in
recovery phase, the WCC normalises followed by platelet.
Sources :
http://www.moh.gov.my/penerbitan/CPG/CPG%20Dengue%20Infection%20PDF%20Final.pdf
QUES 4
CHALLENGES IN THE
DENGUE PREVENTION
ACTIVITIES IN MALAYSIA
• A) Low index of suspicion of dengue cases by
attending doctors
> delayed notification
>delay in giving appropriate treatment
• B)Lack in comunity cooperation and participation in
the dengue prevention and control activities
*stagnant and clogged drains
• C) Health seeking behavior of dengue patient
• a)only 4 % of cases were frm the clinic and
majority from hospital
b)50% of the dengue mortality cases admitted on
day 4 or 5 after onset-delay seeking treatment
c)47% of dengue mortality cases came in already ill
• D)Difficult to break the dengue virus transmission
• *only 35%of patient diagnosed within 3 days from
onset of illness
• *only 19% of dengue cases residence were fogged
within 5 days of onset of illness
5.What is the definition for 'outbreak locality ' and 'hotspot 'in
reference to dengue and chickungunya?
Outbreak locality